Neither option is universally "better." Many laboratories routinely use BAC water because its preservative supports repeated handling, while certain experimental protocols specifically require preservative-free sterile water
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
The table below consolidates the mechanistic distinctions covered throughout this guide into a single reference point
This vendor specialize in selling high-quality peptides for research purposes
Many patients report feeling more alert, focused, and energized within a day or two of their injection
These include: Inappropriate dosing or frequency Lack of proper diagnosis and monitoring Non-sterile injection technique increasing infection risk Absence of medical supervision for adverse reactions Financial cost without clinical benefit Patients should report any suspected adverse reactions to B12 injections via the MHRA Yellow Card scheme
